RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

  • Regulatory NewsRegulatory News

    FDA Concurs With WHO on Rare Lymphoma Linked to Breast Implants

    The US Food and Drug Administration (FDA) on Tuesday said it now concurs with the World Health Organization’s designation of an association between breast implants and the development of anaplastic large cell lymphoma (ALCL), a rare type of non-Hodgkin's lymphoma. "Since 2011, we have strengthened our understanding of this condition and concur with the  World Health Organization designation  of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) as a rare...